A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With a Next-Generation Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

559

Participants

Timeline

Start Date

September 27, 2022

Primary Completion Date

March 26, 2024

Study Completion Date

March 26, 2024

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

BGF MDI HFO 320/14.4/9.6 μg

Budesonide, Glycopyrronium, and Formoterol Fumarate

DRUG

BGF MDI HFA 320/14.4/9.6 μg

Budesonide, Glycopyrronium, and Formoterol Fumarate

Trial Locations (91)

1618

Research Site, Sofia

2300

Research Site, Pernik

2602

Research Site, Dupnitsa

2700

Research Site, Blagoevgrad

2800

Research Site, Sandanski

3600

Research Site, Lom

3700

Research Site, Vidin

5000

Research Site, Veliko Tarnovo

5400

Research Site, Sevlievo

10629

Research Site, Berlin

10787

Research Site, Berlin

10969

Research Site, Berlin

12159

Research Site, Berlin

13156

Research Site, Berlin

19055

Research Site, Schwerin

20070

Research Site, Pamukkale

20253

Research Site, Hamburg

23219

Research Site, Richmond

28209

Research Site, Charlotte

28401

Research Site, Wilmington

29204

Research Site, Columbia

29340

Research Site, Gaffney

29621

Research Site, Anderson

30159

Research Site, Hanover

30449

Research Site, Hanover

33175

Research Site, Miami

33343

Research Site, Mersin

33606

Research Site, Tampa

34020

Research Site, Istanbul

34239

Research Site, Sarasota

35110

Research Site, Izmir

39120

Research Site, Magdeburg

43016

Research Site, Dublin

45359

Research Site, Essen

46383

Research Site, Valparaiso

48431

Research Site, Rheine

56068

Research Site, Koblenz

58452

Research Site, Witten

62290

Research Site, Cuernavaca

63141

Research Site, St Louis

64020

Research Site, Monterrey

65189

Research Site, Wiesbaden

70526

Research Site, Crowley

75069

Research Site, McKinney

75605

Research Site, Longview

76137

Research Site, Karlsruhe

80200

Research Site, Culiacán

85032

Research Site, Phoenix

92663

Research Site, Newport Beach

97130

Research Site, Mérida

97202

Research Site, Portland

97527

Research Site, Grants Pass

02747

Research Site, North Dartmouth

C1414AIF

Research Site, Buenos Aires

C1425BEN

Research Site, Buenos Aires

B1878FNR

Research Site, Quilmes

S2000DEJ

Research Site, Rosario

B1646EBJ

Research Site, San Fernando

B2N 1L2

Research Site, Truro

L1S 2J5

Research Site, Ajax

L7N 3V2

Research Site, Burlington

N1H 6J2

Research Site, Guelph

H1Y 3H5

Research Site, Montreal

G1G 3Y8

Research Site, Québec

G1V 4G5

Research Site, Québec

G2J 0C4

Research Site, Québec

J6E 2B4

Research Site, Saint-Charles-Borromée

G8T 7A1

Research Site, Trois-Rivières

01069

Research Site, Dresden

04910

Research Site, Elsterwerda

06108

Research Site, Halle

D-30173

Research Site, Hanover

03300

Research Site, México

42-500

Research Site, Będzin

85-231

Research Site, Bydgoszcz

05-825

Research Site, Grodzisk Mazowiecki

88-100

Research Site, Inowrocław

58-506

Research Site, Jelenia Góra

31-011

Research Site, Krakow

91-053

Research Site, Lodz

20-412

Research Site, Lublin

05-500

Research Site, Piaseczno

60-185

Research Site, Skórzewo

70-111

Research Site, Szczecin

22-400

Research Site, Zamość

06620

Research Site, Ankara

FY3 7EN

Research Site, Blackpool

NN17 2UR

Research Site, Corby

L1 9ED

Research Site, Liverpool

BH15 2HX

Research Site, Poole

IP24 1JD

Research Site, Thetford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY